Elite Medicine

Elite Medicine operates in West Chester Township, Ohio, under the clinical direction of Dr. Shelli Ridge, DO, a board-certified family medicine physician who also holds board certification in Advanced Diabetes Management. This dual certification positions the clinic to address metabolic health with both foundational medical expertise and specialized training in complex glucose regulation and weight management. Dr. Ridge's approach integrates traditional family medicine principles with functional medicine strategies, allowing patients to receive comprehensive care that addresses root causes rather than isolated symptoms. The clinic's concierge model provides extended appointment times and direct provider access, which supports the detailed metabolic assessments and ongoing monitoring required for peptide-based weight management protocols.

The clinic offers semaglutide therapy as a core component of its metabolic health programs. Semaglutide, a GLP-1 receptor agonist peptide, works by mimicking incretin hormones that regulate insulin secretion and appetite signaling. Elite Medicine structures semaglutide treatment within a broader functional medicine framework that includes nutritional counseling, metabolic lab panels, and body composition tracking. Dr. Ridge's certification in Advanced Diabetes Management informs dosing protocols and patient selection criteria, particularly for individuals with prediabetes, insulin resistance, or metabolic syndrome. The clinic administers semaglutide via subcutaneous injection, with patients receiving instruction on proper technique and injection site rotation. Treatment protocols typically begin with lower doses that are titrated upward based on individual tolerance and response, with regular follow-up to monitor efficacy markers including fasting glucose, hemoglobin A1c, and lipid panels.

Dr. Ridge's clinical philosophy emphasizes the intersection of metabolic optimization and preventive care. Her family medicine background allows her to evaluate how weight management and metabolic health interact with other chronic conditions, medication regimens, and lifestyle factors. The functional medicine component involves investigating underlying contributors to weight gain and metabolic dysfunction, including hormonal imbalances, nutrient deficiencies, inflammatory markers, and stress physiology. This comprehensive evaluation informs individualized treatment plans that may combine semaglutide therapy with targeted supplementation, dietary modifications, and lifestyle interventions. The concierge service model ensures patients have consistent access to Dr. Ridge for questions about side effects, dose adjustments, or concerns that arise between scheduled appointments.

Patients at Elite Medicine in West Chester Township can expect an initial consultation that includes a detailed medical history, current medication review, and discussion of weight management goals and previous attempts. Dr. Ridge typically orders baseline laboratory work to assess thyroid function, metabolic markers, vitamin levels, and other relevant parameters before initiating semaglutide therapy. The clinic provides education on expected timelines for results, common side effects such as nausea or gastrointestinal changes, and strategies to minimize discomfort during dose escalation. Follow-up appointments are scheduled at regular intervals to assess progress, adjust dosing, and address any emerging concerns. The medical spa component of the practice allows patients to access complementary aesthetic treatments that may support body contouring goals as weight loss progresses, though these services are discussed separately from peptide therapy protocols.

Elite Medicine offers both in-person visits at the West Chester Township location and telehealth consultations, providing flexibility for patients across Ohio who may find virtual follow-ups more convenient for routine monitoring appointments. Initial consultations for semaglutide therapy typically occur in person to allow for physical examination and baseline assessments, while subsequent check-ins may be conducted via telemedicine when appropriate. This hybrid model accommodates working professionals and patients with scheduling constraints while maintaining the clinical oversight necessary for safe peptide therapy management. The concierge approach extends to the telehealth platform, with patients receiving the same level of personalized attention and direct provider communication regardless of visit format.